Sarepta Therapeutics, Inc. (SRPT)

First Financial Northwest Revenue

Sarepta Therapeutics had revenue of $744.86M in the quarter ending March 31, 2025, with 80.15% growth. This brings the company's revenue in the last twelve months to $2.23B, up 59.15% year-over-year. In the year 2024, Sarepta Therapeutics had annual revenue of $1.90B with 52.97% growth.

• Revenue (ttm): $2.23B
• Revenue Growth: +59.15%
• P/S Ratio: 0.68
• Revenue / Employee: $1,627,821
• Employees: 1,372
• Market Cap: 1.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.90B	658.64M	52.97%
Dec 31, 2023	1.24B	310.32M	33.26%
Dec 31, 2022	933.01M	231.13M	32.93%
Dec 31, 2021	701.89M	161.79M	29.96%
Dec 31, 2020	540.10M	159.27M	41.82%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.